Why choose graybug vision? At Graybug Vision, we believe that the world should be a place of brilliance, clarity, light and hope. We See You! For people with chronic diseases of the retina and the optic nerve, we develop medicines that make healthy vision more accessible and manageable, promoting better compliance and visual outcomes.What kind of company is graybug? About Graybug Graybug is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve.What is graygray vision? Graybug Vision, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of diseases of the retina and optic nerve.What is graygraybugs gb 102? Graybug’s lead product candidate, GB-102, a formulation of the pan-vascular endothelial growth factor (VEGF) inhibitor, sunitinib malate targeting a six-month or longer dosing regimen, inhibits multiple neovascular pathways for the intravitreal treatment of retinal diseases, including wet age-related macular degeneration.
Company currently does not have any Awards associated. Award Listing. Company currently does not have any Awards associated.
Graybug Vision is developing products to reduce the frequency of dosing for ocular therapies using its injectable and implantable controlled-release technologies, which address low compliance to self-administered eye drops by allowing the physician to manage treatment.